Abstract
The COVID-19 pandemic of 2020 shook the world with its unprecedented scale, affecting over 700 million people and causing nearly 7 million deaths globally. In response, rapid and extraordinary measures were taken, including the development and distribution of COVID-19 vaccines at an unprecedented pace. However, the speed and magnitude of the response have raised questions about the efficacy and ethics of certain measures. To address these concerns, we present a non-comprehensive list of contentious issues that merit discussion and investigation by the scientific and medical communities. These issues encompass public education, ethical considerations, legal implications, policy decisions, regulatory oversight, gaps in scientific knowledge, and concerns related to mass vaccination efforts. By examining these topics, we aim to improve future crisis responses and maintain public trust and participation in vaccination programs. It is essential to learn from the successes and shortcomings of the COVID-19 response to better prepare for future health crises and ensure the safety and well-being of communities worldwide.
Publisher
Peertechz Publications Private Limited
Reference62 articles.
1. 1. Worldometer. COVID coronavirus statistics; 2024. https://www.worldometers.info/coronavirus/
2. 2. WHO. COVID-19 vaccination, World data, World Health Organization (WHO); 2024. https://data.who.int/dashboards/covid19/vaccines?n=c
3. 3. Turyasingura N, James WG, Vermund SH. COVID-19 vaccine equity in Africa. Trans R Soc Trop Med Hyg. 2023 Jun 2;117(6):470-472. doi: 10.1093/trstmh/trac130. PMID: 36622662; PMCID: PMC10235805.
4. 4. OECD. Enhancing public trust in COVID-19 vaccination: The role of governments, The Organisation for Economic Co-operation and Development (OECD); 2021. https://www.oecd.org/coronavirus/policy-responses/enhancing-public-trust-in-covid-19-vaccination-the-role-of-governments-eae0ec5a/
5. 5. Stevens DL, Bryant AE. Endemic, epidemic and pandemic infections: the roles of natural and acquired herd immunity. Curr Opin Infect Dis. 2023 Jun 1;36(3):171-176. doi: 10.1097/QCO.0000000000000916. Epub 2023 Mar 20. PMID: 36939580.